Results per Page:
Fred Hutch expands its research capacity in South Lake Union
Three new buildings will boost recruitment and strengthen science
When it comes to low-affinity HER2 CAR T cells, less is more
From the Riddell lab, Translational Science and Therapeutics Division and Cancer Immunology Program
A tale of two T cells in Merkel Cell Carcinoma
From the Newell Lab, Vaccines and Infectious Disease Division
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
Behnke family commits $15M to support Fred Hutch campaign
Patient lodging in South Lake Union will be renamed in family’s honor
Abnormal bone marrow findings post CAR-T cell therapy help uncover responses to treatment
From the Yeung and Naresh labs, Translational Sciences and Therapeutics Division
Macrophages predict response to immunotherapy in Merkel cell carcinoma
From the Nghiem lab, Fred Hutch Clinical Research Division & UW Dermatology
One step closer to personalized oncology for chemo-resistant ovarian cancer
From the Paulovich Lab, Translational Science and Therapeutics Division
AI rides shotgun in the quest for better cancer diagnostics
From the Liu Lab, UW College of Engineering and School of Medicine, and the Grady Lab, Translational Science and Therapeutics and Public Health Sciences Divisions
(Bio)marking the spot – utilizing droplet digital PCR for risk biomarker identification in colorectal cancer
From the Grady Lab, Translational Science and Therapeutics
Transformative $78M gift to establish new precision oncology institute
Gift will accelerate center’s leadership in the future of cancer research